More articles from Adult Brain

Serial T1WI and ¹H-MR spectroscopy data were acquired in 15 healthy individuals at normohydration, at 12 hours of dehydration, and during 1 hour of oral rehydration. Osmotic challenges were monitored by serum measures, including osmolality and hematocrit. With dehydration, serum osmolality increased by 0.67% and brain tissue fluid decreased by 1.63%. MR imaging morphometry demonstrated corresponding decreases of cortical thickness and volumes of the whole brain, cortex, white matter, and hypothalamus/thalamus. These changes reversed during rehydration. The authors conclude that it is essential to control for hydration levels in studies on brain morphometry and metabolism in order to avoid confounding the findings.

Patients with suspected idiopathic normal pressure hydrocephalus (NPH) on the basis of the ventriculomegaly and a triad of symptoms underwent the CSF tap test. CSF volumes were extracted from a T2-weighted 3D spin-echo SPACE sequence on 3T MR imaging and were quantified semiautomatically. Twenty-four patients with tap-positive idiopathic NPH, 25 patients without response to the tap test, and 23 age-matched controls were included. The CSF volume of the parietal convexity had the highest area under the ROC curve in the discrimination of the tap-test response (0.768), followed by the z-Evans Index (0.758), and the upper-to-lower subarachnoid space ratio index (0.723). CSF volume of the parietal convexity of less than 38 mL, upper-to-lower subarachnoid space ratio of less than 0.33, and a z-Evans Index of greater than 0.42 are the newly proposed useful indices for idiopathic NPH diagnosis.

These authors retrospectively evaluated 12 patients with natalizumab–progressive multifocal leukoencephalopathy (PML), 5 with PML from other causes, and 55 patients with MS without progressive PML for comparison. They observed T2* or SWI signal abnormalities at the chronic stage in all patients with PML, but in patients without PML no areas of low SWI signal intensity were detected. PML—related to natalizumab or not—induces brain susceptibility changes within U-fibers or deep gray matter that are visible on T2* or SWI and potentially explained by iron deposition.